OBJ Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
1,394.60
1,339.40
1,650.40
1,056.60
Cost of Goods Sold (COGS) incl. D&A
1,184.40
2,018.60
2,181.80
2,856.50
1,913.90
Gross Income
1,184.40
624.00
842.40
1,206.10
857.30
SG&A Expense
1,933.70
1,487.90
2,382.70
1,690.40
1,436.00
EBIT
3,118.20
2,111.90
3,225.10
2,896.60
2,293.30
Non Operating Income/Expense
8.90
346.50
495.80
282.30
514.50
Interest Expense
29.10
15.30
14.00
14.00
14.00
Pretax Income
3,012.00
2,353.50
3,555.40
3,044.20
1,698.80
Income Tax
806.70
-
-
-
-
Consolidated Net Income
2,205.40
2,353.50
3,555.40
3,044.20
1,698.80
Net Income
2,205.40
2,353.50
3,555.40
3,044.20
1,698.80
Net Income After Extraordinaries
2,205.40
2,353.50
3,555.40
3,044.20
1,698.80
Net Income Available to Common
2,205.40
2,353.50
3,555.40
3,044.20
1,698.80
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
Basic Shares Outstanding
1,416,236.00
1,579,534.60
1,738,958.40
1,775,028.90
-
EPS (Diluted)
0.00
0.00
0.00
0.00
-
Diluted Shares Outstanding
1,416,236.00
1,579,534.60
1,738,958.40
1,775,028.90
-
EBITDA
3,094.20
2,074.50
3,148.80
2,750.30
2,196.50
Non-Operating Interest Income
144.20
120.30
179.50
148.70
94.10

About OBJ

View Profile
Address
284 Oxford Street
Leederville Western Australia (WA) 6007
Australia
Employees -
Website http://www.obj.com.au
Updated 07/08/2019
OBJ Ltd. operates as a research developer of magnetic, micro-array drug and ingredient delivery technologies. It designs and develops magnetic enhanced, magnetic micro-array and powerless drug delivery technologies for use in pharmaceutical, cosmetic, consumer healthcare, homecare, and industrial applications. The firm provides partnering services in the creation of next generation product.